These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 34669197)

  • 41. Incidence and outcome of gestational trophoblastic disease in lower Egypt.
    Zakaria A; Hemida R; Elrefaie W; Refaie E
    Afr Health Sci; 2020 Mar; 20(1):73-82. PubMed ID: 33402895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetics of gestational trophoblastic neoplasia: an update for the clinician.
    Alifrangis C; Seckl MJ
    Future Oncol; 2010 Dec; 6(12):1915-23. PubMed ID: 21142864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia.
    Gadducci A; Lanfredini N; Cosio S
    Gynecol Endocrinol; 2015; 31(9):673-8. PubMed ID: 26288335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current chemotherapeutic options for the treatment of gestational trophoblastic disease.
    Braga A; Paiva G; Cattai CJ; Elias KM; Horowitz NS; Berkowitz RS
    Expert Opin Pharmacother; 2023 Feb; 24(2):245-258. PubMed ID: 36399723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imaging in Gestational Trophoblastic Disease.
    Lin LH; Polizio R; Fushida K; Francisco RPV
    Semin Ultrasound CT MR; 2019 Aug; 40(4):332-349. PubMed ID: 31375173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gestational Trophoblastic Disease: Clinical and Imaging Features.
    Shaaban AM; Rezvani M; Haroun RR; Kennedy AM; Elsayes KM; Olpin JD; Salama ME; Foster BR; Menias CO
    Radiographics; 2017; 37(2):681-700. PubMed ID: 28287945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
    Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
    Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of gestational trophoblastic diseases in Japan--a review.
    Sasaki S
    Placenta; 2003 Apr; 24 Suppl A():S28-32. PubMed ID: 12842411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles.
    Sato A; Usui H; Shozu M
    Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review on management of gestational trophoblastic neoplasia.
    Sharami SRY; Saffarieh E
    J Family Med Prim Care; 2020 Mar; 9(3):1287-1295. PubMed ID: 32509606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gestational Trophoblastic Disorders: An Update in 2015.
    Stevens FT; Katzorke N; Tempfer C; Kreimer U; Bizjak GI; Fleisch MC; Fehm TN
    Geburtshilfe Frauenheilkd; 2015 Oct; 75(10):1043-1050. PubMed ID: 26556906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center.
    Vargas R; Barroilhet LM; Esselen K; Diver E; Bernstein M; Goldstein DP; Berkowitz RS
    J Reprod Med; 2014; 59(5-6):188-94. PubMed ID: 24937955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53.
    Soper JT; Mutch DG; Schink JC;
    Gynecol Oncol; 2004 Jun; 93(3):575-85. PubMed ID: 15196847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A 10-Year Clinical Experience of Gestational Trophoblastic Disease at Rajavithi Hospital, 2001-2010.
    Yanaranop M; Potikul C; Tuipae S
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S17-27. PubMed ID: 27266212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The current situation of health services for hydatidiform mole in Cambodia.
    Yamamoto E; Kanal K; Soeung SC; Fujita N; Krang S; Long-Hay P; Nishino K; Niimi K; Hamajima N
    J Obstet Gynaecol Res; 2021 Oct; 47(10):3652-3660. PubMed ID: 34342367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia.
    Strohl AE; Lurain JR
    Gynecol Oncol; 2016 May; 141(2):276-280. PubMed ID: 26896825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.
    Lurain JR
    Am J Obstet Gynecol; 2010 Dec; 203(6):531-9. PubMed ID: 20728069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gestational trophoblastic disease in Switzerland: retrospective study of the impact of a regional reference centre.
    Fehlmann A; Benkortbi K; Rosseel G; Meyer-Hamme U; Tille JC; Sloan-Bena F; Paoloni-Giacobino A; Rougemont AL; Bodmer A; Botsikas D; Mathevet P; Petignat P; Undurraga Malinverno M
    Swiss Med Wkly; 2021 Feb; 151():w20406. PubMed ID: 33578430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.